el-Kashef H A, Hofman W F, Ehrhart I C
Department of Physiology and Endocrinology, Medical College of Georgia, Augusta 30912-3000.
Am J Physiol. 1989 Dec;257(6 Pt 2):H1977-82. doi: 10.1152/ajpheart.1989.257.6.H1977.
The effects of lipoxygenase inhibition and cyclooxygenase plus lipoxygenase inhibition on the pressor responses to serotonin (5-HT), acetylcholine (ACh), and norepinephrine (NE) were studied in the isolated, blood-perfused dog lung. Bolus doses of 50-250 micrograms 5-HT, 1-5 mumol ACh, and 10-50 micrograms NE were given before and after the lipoxygenase inhibitor, nordihydroguaiaretic acid (NDGA), or the cyclooxygenase inhibitor, meclofenemate (Meclo), followed by NDGA. Lobar vascular resistance (LVR) was partitioned into upstream (Ra) and downstream (Rv) segments by venous occlusion. 50 microM NDGA did not change base-line LVR, Ra, or Rv; however, 100 microM NDGA increased base-line LVR (P less than 0.05) without increasing Ra or Rv (P greater than 0.05). Neither 50 or 100 microM NDGA affected the pressor response to 5-HT, ACh, or NE; however, the response to 50 micrograms 5-HT was slightly enhanced. Meclo increased base-line LVR (P less than 0.05) and subsequent addition of 50 microM NDGA did not change LVR (P greater than 0.05) from post-Meclo values. The LVR increase to both 5-HT and ACh was potentiated after Meclo (P less than 0.05) and 50 microM NDGA after Meclo did not change the LVR increase to either 5-HT or ACh. In contrast, Meclo did not enhance the pressor response to NE, and addition of 50 microM NDGA after Meclo diminished the increase to 20 and 50 micrograms NE (P less than 0.05). Our results suggest that unlike cyclooxygenase inhibition, lipoxygenase inhibition does not increase base-line LVR or the pressor response to either 5-HT or ACh.(ABSTRACT TRUNCATED AT 250 WORDS)
在离体血液灌注的犬肺中,研究了脂氧合酶抑制以及环氧化酶加脂氧合酶抑制对血清素(5-羟色胺,5-HT)、乙酰胆碱(ACh)和去甲肾上腺素(NE)升压反应的影响。在给予脂氧合酶抑制剂去甲二氢愈创木酸(NDGA)或环氧化酶抑制剂甲氯灭酸钠(Meclo)(随后给予NDGA)之前及之后,分别给予50 - 250微克的5-HT、1 - 5微摩尔的ACh以及10 - 50微克的NE静脉推注剂量。通过静脉闭塞将肺叶血管阻力(LVR)分为上游(Ra)和下游(Rv)段。50微摩尔的NDGA未改变基线LVR、Ra或Rv;然而,100微摩尔的NDGA增加了基线LVR(P < 0.05),但未增加Ra或Rv(P > 0.05)。50或100微摩尔的NDGA均未影响对5-HT、ACh或NE的升压反应;不过,对50微克5-HT的反应略有增强。Meclo增加了基线LVR(P < 0.05),随后添加50微摩尔的NDGA并未使LVR相对于Meclo给药后的值发生改变(P > 0.05)。Meclo给药后,对5-HT和ACh的LVR增加均增强(P < 0.05),Meclo后添加50微摩尔的NDGA并未改变对5-HT或ACh的LVR增加。相反,Meclo并未增强对NE的升压反应,Meclo后添加50微摩尔的NDGA使对20和50微克NE的增加减弱(P < 0.05)。我们的结果表明,与环氧化酶抑制不同,脂氧合酶抑制不会增加基线LVR或对5-HT或ACh的升压反应。(摘要截短于250字)